Summary: Stratfor explains one aspect of our free market globalized world -- the export of fentanyl to America by Mexico's capitalist cartels. They saw the market and successfully met its demands, despite powerful opposition. As for Mexico, for a decade geopolitical experts have prophesied its doom from the growing power of the cartels. So far … Continue reading Stratfor: Mexico’s entrepreneurs provide the fentanyl that America wants!
Summary: America has a drug problem, a symptom some deeper sickness of our minds or souls. Sick people often ignore warnings that would allow them to respond and recover. So it is with nations. It's time for us to ask what is wrong with America. America is among the most drugged major nations in the history … Continue reading America’s rising tide of drug overdoses, a symptom of deeper problems
Summary: Here Stratfor provides a status report on the fight against superbugs -- drug-resistant germs -- one of the great threats facing us in the 21st century. The last large pandemic in the West was a century ago. Another is coming. We have time to prepare. The Insidious Threat of Drug-Resistant Disease Stratfor, 4 October … Continue reading Stratfor: The superbugs are coming. We have time to prepare.
Summary: The next industrial revolution has begun, but this one will improve not just our machines but ourselves. How we use these powerful innovations will help shape our society into utopia or dystopia, dream or nightmare. First of 2 posts today. Two recent posts illustrate the difficulty of seeing the next phases of the industrial … Continue reading Potentially horrific effects of drugs and machines making people smarter & stronger
Summary: Powerful trends occur when multiple waves combine. So it is with the biotech bubble, where our inability to learn about our out-of-control financial sector meets the grifter economy. The results will be spectacular, and typical of our time -- powerful benefits to society manipulated to produce massive profits for the 1%. As you read … Continue reading Don’t ask if there’s a biotech bubble. Ask why we have another bubble.